Dementia is a broad term encompassing a group of symptoms that impact cognitive functions like memory, thinking, and social abilities, significantly interfering with daily life. It’s not a singular disease but rather a syndrome resulting from various underlying brain disorders. While memory loss is often an early indicator, it’s crucial to remember that memory issues alone do not equate to dementia, as they can stem from numerous other causes. Alzheimer’s disease remains the most prevalent cause of dementia, particularly among older adults, but various other conditions can also lead to dementia. Importantly, depending on the underlying cause, some dementia symptoms can be reversible.
Symptoms of Dementia
Dementia manifests differently depending on the cause, but several common symptoms point towards cognitive and psychological changes.
Cognitive Changes
- Memory Loss: Frequently noticed by family members or caregivers, this goes beyond occasional forgetfulness and impacts daily recall.
- Communication Difficulties: Struggling to find the right words or follow conversations.
- Visuospatial Problems: Difficulty with spatial orientation, such as getting lost in familiar places or misjudging distances, even while driving.
- Impaired Reasoning and Problem-Solving: Challenges in making decisions, solving simple problems, or understanding consequences.
- Difficulty with Complex Tasks: Inability to manage multi-step activities that were once routine, like following a recipe or managing finances.
- Planning and Organization Issues: Struggling to plan events, organize thoughts, or follow structured routines.
- Poor Coordination and Motor Control: Difficulties with balance, fine motor skills, and movement precision.
- Confusion and Disorientation: Feeling lost in time or place, not recognizing familiar surroundings or people.
Psychological Changes
- Personality Shifts: Noticeable alterations in temperament, becoming withdrawn, irritable, or apathetic.
- Depression: Persistent sadness, loss of interest in activities, and other depressive symptoms.
- Anxiety: Increased worry, nervousness, and restlessness, often disproportionate to situations.
- Agitation: Restlessness, pacing, irritability, and sometimes aggressive behavior.
- Inappropriate Behavior: Acting out of character or exhibiting socially unacceptable actions.
- Paranoia (Suspiciousness): Unwarranted distrust and suspicion of others, sometimes believing people are stealing or plotting against them.
- Hallucinations: Seeing or hearing things that are not real, causing distress and confusion.
When to Seek Medical Advice
It’s crucial to consult a healthcare professional if you or someone you know experiences memory problems or other dementia symptoms. Determining the underlying cause is essential, as some conditions mimicking dementia are treatable. Early diagnosis and intervention can significantly improve the quality of life and manage symptoms effectively.
Causes of Dementia
Dementia arises from damage to brain cells and their connections. The specific symptoms depend on the affected brain region. Various conditions can lead to dementia, and they are often categorized by shared characteristics, such as the type of protein deposits or the affected brain area. Some conditions and medications can also mimic dementia symptoms, and addressing underlying issues like vitamin deficiencies can sometimes reverse these symptoms.
Progressive Dementias
These types of dementia worsen over time and are irreversible.
-
Alzheimer’s Disease: The most common cause of dementia. Characterized by plaques of beta-amyloid protein and tangles of tau protein in the brain, disrupting brain cell function. While the exact causes are not fully understood, genetics play a role in some cases, with apolipoprotein E4 (APOE) being a significant risk gene.
-
Vascular Dementia: Caused by damage to blood vessels supplying the brain, often due to stroke or other cerebrovascular diseases. This disrupts blood flow and oxygen supply to the brain, leading to cognitive decline. Symptoms often include problems with problem-solving, slow thinking, and difficulty focusing, sometimes more pronounced than memory loss.
-
Lewy Body Dementia (LBD): Characterized by abnormal protein deposits called Lewy bodies in the brain. LBD shares symptoms with both Alzheimer’s and Parkinson’s disease. Common symptoms include visual hallucinations, acting out dreams (REM sleep behavior disorder), and fluctuating alertness, along with movement difficulties similar to Parkinson’s.
-
Frontotemporal Dementia (FTD): A group of disorders resulting from the degeneration of nerve cells in the frontal and temporal lobes of the brain. These areas are crucial for personality, behavior, and language. FTD often presents with significant changes in personality, social behavior, and language abilities, sometimes at a younger Average Age Dementia Diagnosis compared to Alzheimer’s.
-
Mixed Dementia: A combination of different types of dementia pathologies in the brain, commonly Alzheimer’s, vascular dementia, and Lewy body dementia. Mixed dementia is increasingly recognized, especially in older adults, and can present a complex symptom profile.
Other Disorders Linked to Dementia
- Huntington’s Disease: A genetic disorder causing progressive nerve cell degeneration in the brain and spinal cord. Cognitive decline is a prominent symptom, typically appearing around average age dementia diagnosis of 30 or 40.
- Traumatic Brain Injury (TBI): Especially repetitive head trauma, can lead to dementia. The symptoms vary based on the injured brain area and can include memory loss, depression, speech impairment, and parkinsonism. Symptoms might emerge years after the injury.
- Creutzfeldt-Jakob Disease (CJD): A rare, fatal brain disorder caused by infectious proteins called prions. Symptoms usually manifest after average age dementia diagnosis of 60 and progress rapidly.
- Parkinson’s Disease Dementia: Many individuals with Parkinson’s disease eventually develop dementia, known as Parkinson’s disease dementia.
Reversible Dementia-like Conditions
Some conditions can mimic dementia symptoms but are treatable and reversible:
- Infections and Immune Disorders: Infections, fever, multiple sclerosis, and other autoimmune conditions can cause temporary cognitive impairment.
- Metabolic and Endocrine Problems: Thyroid disorders, blood sugar imbalances, and electrolyte abnormalities can lead to dementia-like symptoms.
- Nutrient Deficiencies: Lack of vitamins like B1, B6, B12, copper, and vitamin E, as well as dehydration, can cause cognitive dysfunction.
- Medication Side Effects: Reactions to medications or interactions between multiple drugs can induce dementia-like symptoms.
- Subdural Bleeding: Bleeding between the brain’s surface and its outer covering, common after falls in older adults, can present with dementia-like symptoms.
- Brain Tumors: Rarely, brain tumors can cause dementia due to the damage they inflict.
- Normal-Pressure Hydrocephalus: Fluid buildup in brain ventricles can lead to walking difficulties, incontinence, and memory loss.
Risk Factors for Dementia
Several factors increase dementia risk, some unchangeable, others modifiable.
Unchangeable Risk Factors
- Age: The most significant risk factor, with risk increasing substantially after 65. However, dementia is not an inevitable part of aging and can occur at younger ages. The average age dementia diagnosis for Alzheimer’s is often in the mid-60s and later, but early-onset forms exist.
- Family History: Having a family history of dementia increases risk, though many with family history do not develop it, and vice versa. Genetic testing can identify specific gene mutations that heighten risk.
- Down Syndrome: Individuals with Down syndrome have a significantly higher risk of early-onset Alzheimer’s by middle age.
Modifiable Risk Factors
- Diet and Exercise: A healthy lifestyle, including a diet rich in fish, fruits, vegetables, and healthy oils, along with regular exercise, cognitive training, and social engagement, is associated with a reduced risk of cognitive decline. The Mediterranean diet, in particular, is linked to better cognitive function.
- Excessive Alcohol Consumption: Chronic heavy alcohol use is linked to an increased risk of dementia, especially early-onset dementia.
- Cardiovascular Risk Factors: Conditions like obesity, hypertension, high cholesterol, atherosclerosis, diabetes, and smoking significantly increase dementia risk. Managing these cardiovascular risks is crucial for brain health.
- Untreated Hearing or Vision Loss: Hearing loss is strongly associated with a higher dementia risk, and vision loss may also contribute. Addressing these sensory impairments can potentially lower risk.
- Depression: Late-life depression may be an early indicator or a risk factor for dementia.
- Air Pollution: Exposure to air pollution, particularly from traffic and burning wood, is linked to increased dementia risk.
- Head Trauma: Severe or repeated head trauma elevates the risk of Alzheimer’s and other dementias.
- Sleep Disturbances: Sleep apnea and other sleep disorders may increase dementia risk.
- Vitamin and Nutrient Deficiencies: Low levels of vitamins D, B6, B12, and folate can increase dementia risk.
- Memory-Worsening Medications: Certain medications, like sleep aids containing diphenhydramine and urinary urgency drugs like oxybutynin, can worsen memory and potentially increase dementia risk.
Complications of Dementia
Dementia can severely impact bodily functions and daily living, leading to various complications:
- Poor Nutrition: Reduced appetite and difficulty eating can lead to malnutrition. In advanced stages, swallowing difficulties increase risk of aspiration.
- Pneumonia: Aspiration pneumonia is a significant risk due to swallowing problems, where food or liquid enters the lungs.
- Inability to Perform Self-Care: As dementia progresses, individuals lose the ability to perform basic self-care tasks like bathing, dressing, and toileting, requiring significant assistance.
- Safety Challenges: Dementia poses safety risks in everyday situations like driving, cooking, and living alone.
- Death: In late-stage dementia, complications like infections, often pneumonia, can lead to coma and death.
Prevention Strategies for Dementia
While there’s no guaranteed way to prevent dementia, adopting healthy lifestyle habits can significantly reduce risk:
- Maintain Cognitive Activity: Engage in mentally stimulating activities like reading, puzzles, and word games to keep the brain active.
- Stay Physically and Socially Active: Regular exercise and social interaction are linked to delayed dementia onset and reduced symptom severity. Aim for at least 150 minutes of moderate-intensity exercise weekly.
- Quit Smoking: Smoking, especially in middle age and beyond, increases dementia and vascular disease risk. Quitting smoking is beneficial for brain health.
- Ensure Adequate Vitamin Intake: Maintain sufficient vitamin D levels through diet, supplements, and sunlight. Consider a daily B-complex and vitamin C supplement.
- Manage Cardiovascular Risk Factors: Control high blood pressure, cholesterol, and diabetes through medication and lifestyle changes. Maintain a healthy weight.
- Treat Existing Health Conditions: Seek treatment for depression and anxiety.
- Adopt a Healthy Diet: Follow a Mediterranean-style diet rich in fruits, vegetables, whole grains, and omega-3 fatty acids to promote brain and cardiovascular health.
- Prioritize Good Sleep: Practice good sleep hygiene and address sleep disorders like sleep apnea.
- Address Hearing Loss: Treat hearing loss promptly with hearing aids, as it’s linked to cognitive decline.
- Regular Eye Exams and Vision Correction: Ensure regular eye exams and correct vision problems, as untreated vision loss may increase dementia risk.
By Mayo Clinic Staff
Sept. 25, 2024
References
- What is dementia? Alzheimer’s Association. https://www.alz.org/alzheimers-dementia/what-is-dementia. Accessed April 24, 2023.
- Dementias. https://www.ninds.nih.gov/Disorders/Patient-Caregiver-Education/Hope-Through-Research/Dementia-Hope-Through-Research. Accessed April 24, 2023.
- Larson EB. Evaluation of cognitive impairment and dementia. https://www.uptodate.com/contents/search. Accessed April 24, 2023.
- Rao RV, et al. Rationale for multi-factorial approach for the reversal of cognitive decline in Alzheimer’s disease and MCI: A review. International Journal of Molecular Sciences. 2023; doi:10.3390/ijms24021659.
- Press D, et al. Management of the patient with dementia. https://www.uptodate.com/contents/search. Accessed April 24, 2023.
- Livingston G, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. The Lancet. 2020; doi:10.1016/S0140-6736(20)30367-6.
- Luo G, et al. Effectiveness of non-pharmacological therapies on cognitive function in patients with dementia — A network meta-analysis of randomized controlled trials. Frontiers in Aging: Neuroscience. 2023; doi:10.3389/fnagi.2023.1131744.
- Creutzfeldt-Jakob disease, classic (CJD): Occurrence and transmission. Centers for Disease Control and Prevention. https://www.cdc.gov/prions/cjd/occurrence-transmission.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fprions%2Fcjd%2Foccurance-transmisison.html. Accessed April 24, 2023.
- Palimariciuc M, et al. The quest for neurodegenerative disease treatment — Focusing on Alzheimer’s disease personalised diets. Current Issues in Molecular Biology. 2023; doi:10.3390/cimb45020098.
- Dementia. Merck Manual Professional Version. https://www.merckmanuals.com/professional/neurologic-disorders/delirium-and-dementia/dementia. Accessed April 24, 2023.
- Press D, et al. Prevention of dementia. https://www.uptodate.com/contents/search. Accessed April 24, 2023.
- Sleep issues and sundowning. Alzheimer’s Association. https://www.alz.org/help-support/caregiving/stages-behaviors/sleep-issues-sundowning. Accessed May 2, 2023.
- Medications for memory. Alzheimer’s Association. https://www.alz.org/alzheimers-dementia/treatments/medications-for-memory. Accessed April 24, 2023.
- How to communicate with a person with dementia. Alzheimer’s Society. https://www.alzheimers.org.uk/about-dementia/symptoms-and-diagnosis/symptoms/tips-for-communicating-dementia. Accessed April 24, 2023.
- Press D, et al. Management of neuropsychiatric symptoms of dementia. https://www.uptodate.com/search/contents. Accessed May 2, 2023.
- Leqembi (approval letter). Biologic License Application 761269. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761269. Accessed July 7, 2023.
- Lecanemab approved for treatment of early Alzheimer’s disease. Alzheimer’s Association. https://www.alz.org/alzheimers-dementia/treatments/lecanemab-leqembi. Accessed May 4, 2023.
- Van Dyck CH, et al. Lecanemab in early Alzheimer’s disease. New England Journal of Medicine. 2023; doi:10.1056/NEJMoa2212948.
- Shi M, et al. Impact of anti-amyloid-β monoclonal antibodies on the pathology and clinical profile of Alzheimer’s disease: A focus on aducanumab and lecanemab. Frontiers in Aging and Neuroscience. 2022; doi:10.3389/fnagi.2022.870517.
- Cummings J, et al. Alzheimer’s disease drug development pipeline: 2022. Alzheimer’s and Dementia. 2022; doi:10.1002/trc2.12295.
- Oxybutynin oral. Facts & Comparisons eAnswers. https://fco.factsandcomparisons.com. Accessed April 28, 2023.
- Diphenhydramine oral. Facts & Comparisons eAnswers. https://fco.factsandcomparisons.com. Accessed April 28, 2023.
- Rashad A, et al. Donanemab for Alzheimer’s disease: A systematic review of clinical trials. Healthcare. 2022; doi:10.3390/healthcare11010032.
- Budson AE, et al. Cholinesterase inhibitors. In: Memory Loss, Alzheimer’s Disease, and Dementia. 3rd ed. Elsevier; 2022. https://www.clinicalkey.com. Accessed May 4, 2023.
- Leqembi (prescribing information). Eisai; 2023. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=761269. Accessed July 10, 2023.
- Mintun MA, et al. Donanemab in early Alzheimer’s disease. New England Journal of Medicine. 2021; doi:10.1056/NEJMoa2100708.
- Graff-Radford J (expert opinion). Mayo Clinic. May 15, 2023.
- Ami TR. Allscripts EPSi. Mayo Clinic. May 17, 2023.
- Kisunla (approval letter). Biologic License Application 761248. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=BasicSearch.process. Accessed July 9, 2024.
- Sims JR, et al. Donanemab in early symptomatic Alzheimer disease: The TRAILBLAZER-ALZ 2 randomized clinical trial. JAMA. 2023; doi:10.1001/jama.2023.13239.
- Kisunla (prescribing information). Eli Lilly and Company; 2024. https://www.lilly.com/. Accessed July 3, 2024.
- Livingston G, et al. Dementia prevention, intervention and care: 2024 report of the Lancet standing Commission. Lancet. 2024; doi:10.1016/S0140-6736(24)01296-0.